Annals of Dermatological Research (ADR) is a leading international, peer-reviewed open access journal dedicated to the field of dermatology, skin biology, and clinical research related to skin health and diseases. ADR provides a trusted platform for disseminating high-quality, evidence-based research that contributes to advancing dermatological knowledge and improving patient care.

Our Mission

The mission of ADR is to promote scholarly exchange and the dissemination of scientific discoveries that improve the prevention, diagnosis, and treatment of skin diseases. The journal encourages submissions from diverse fields including clinical dermatology, cosmetic dermatology, dermatopathology, immunodermatology, pediatric dermatology, and skin oncology.

ADR is committed to editorial independence, global accessibility, and scientific integrity. We follow the highest standards set by COPE, ICMJE, and DOAJ to ensure transparency, fairness, and inclusivity in publishing.

Why Publish with ADR?

Global Visibility: Articles are openly accessible worldwide without subscription barriers.
Rigorous Peer Review: Manuscripts undergo a robust, double-blind peer review process.
Rapid Publication: Accepted articles are published online promptly with DOI assignment.
Interdisciplinary Scope: Covers all aspects of dermatology and related biomedical sciences.
Ethical Standards: Adheres strictly to COPE and ICMJE guidelines for research and publishing ethics.

History and Background

ADR was founded with the vision of creating a specialized platform for dermatology research, bridging the gap between clinical practice and laboratory science. While dermatology is one of the oldest medical specialties, modern challenges such as skin cancers, autoimmune diseases, chronic inflammatory conditions, and cosmetic interventions demand new approaches and global dialogue. ADR serves this need by providing a credible, indexed, and researcher-friendly publication channel.

Editorial Independence

Our editorial board comprises leading dermatologists, researchers, and clinicians from around the world. ADR ensures that editorial decisions are based purely on academic merit and relevance, free from commercial or political influence. Editorial independence is protected through clear conflict-of-interest policies and transparency in review processes.

Commitment to Open Science

ADR strongly supports open science practices, including data sharing, reproducibility, and transparent peer review. We encourage authors to deposit supplementary materials, data sets, and protocols in recognized repositories to maximize scientific value and community engagement.

Audience

The journal is designed for dermatologists, clinicians, researchers, academicians, industry professionals, and policymakers engaged in skin health. By fostering multidisciplinary collaboration, ADR contributes to better prevention strategies, diagnostic techniques, and therapeutic solutions.

Ethical & Professional Standards

ADR follows the ethical publishing standards of COPE, ICMJE, WAME, and DOAJ. Authors, editors, and reviewers are expected to uphold principles of integrity, accountability, and respect. Plagiarism, data manipulation, duplicate publication, and unethical practices are strictly prohibited.

FAQs About ADR

Is ADR indexed?

Yes. ADR actively pursues inclusion in leading academic indexing services to maximize discoverability and citation impact.

Does ADR charge APCs?

ADR follows an open access publishing model with a transparent Article Processing Charge (APC) policy, details of which are provided in the APC section of this website.

What is the review timeline?

Initial editorial decisions are usually communicated within 2–3 weeks of submission. Peer review may extend this depending on reviewer availability and manuscript complexity.

Can I submit supplementary data?

Yes. ADR encourages authors to submit datasets, video abstracts, and supplementary files to enhance research impact.

Future Directions

ADR aims to become a cornerstone in global dermatological research by promoting cross-border collaboration, incorporating artificial intelligence in dermatology research analytics, and fostering clinical guidelines for practitioners. The journal will continue to evolve with the latest advancements in skin biology and therapeutic sciences.